Vimta Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022
May 12, 2022 at 09:34 am EDT
Share
Vimta Labs Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 278.28 million compared to INR 210.68 million a year ago. Revenue was INR 279.73 million compared to INR 211.51 million a year ago. Net income was INR 41.33 million compared to INR 21.41 million a year ago. Basic earnings per share from continuing operations was INR 18.7 compared to INR 9.68 a year ago. Diluted earnings per share from continuing operations was INR 18.32 compared to INR 9.68 a year ago.
Vimta Labs Limited is engaged in the business of contract research and testing organization. The Company is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include Drug discovery, development, and drug life cycle management support services; Preclinical research and testing services for medical device companies; Contract research and testing for agrochemical and specialty chemical companies; and Food testing and analytical development services to support manufacturers, processors, farmers, and retailers; Clinical diagnostics services to patients, clinicians, and hospitals, and environmental regulatory services such as impact assessments and post project monitoring, to various industries, such as power and infrastructure.
VIMTA LABS LIMITED 
